Article
Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility.
Gynecologic oncology - 1 Jun 2012
Landon G, Stewart J, Deavers M, Lu K, Sneige N
Abstract excerpt
OBJECTIVE: To evaluate the utility of peritoneal washing cytology (PWC) for detecting occult primary peritoneal carcinoma in patients with BRCA1 or BRCA2 mutations, we reviewed PWCs obtained during risk-reducing salpingo-oophorectomy (RRSO) from 117 patients at our institution and correlated the results with surgical pathology findings. METHODS: Records of 128 PWCs from 125 patients with BRCA1 or BRCA2 mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
